Tradestie Institutional Equity Comparison Engine
RCEL vs VVOS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RCEL Overall Edge
RCEL Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avita Medical, Inc. Common Stock (RCEL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RCEL trades at 10.3x Forward P/E with -33.9% operating margin (+53.1% YoY revenue) versus VVOS at N/M Forward P/E and -107.9% operating margin (+34.9% YoY). In options structure, RCEL sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
RCEL
RCEL 10.3x vs VVOS N/M Fwd P/E
Growth & Margin Winner
RCEL
Op Margin -33.9% vs -107.9% ยท YoY +53.1% vs +34.9%
Momentum & Technical Winner
RCEL
1Y +295.4% vs -97.7% ยท 52W Pos 82% vs 0%
Options & Structure Winner
RCEL
CONSOLIDATION (6th %ile IV) vs BREAKDOWN (N/A IV)
RCEL
NASDAQ
Avita Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$15.62
-2.31% 1D
Market Cap
$506.7M
1M Return
+1.3%
1Y Return
+295.44%
Forward P/E
10.3x
Unified AI Score
45.6 / 100
HOLD
Tech 32.0
Fund 44.0
Flow 69.0
Mom 31.1
VVOS
NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap
$1.9M
1M Return
-59.25%
1Y Return
-97.71%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RCEL +295.44%
VVOS -97.71%
Spread: +393.15 pp (RCEL Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | RCEL Revenue | VVOS Revenue | RCEL Op. Margin | VVOS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -1489.9% | N/A | RCEL |
| FY2019 | $10M | $10M | -466.4% | -92.8% | VVOS |
| FY2020 | $10M | $10M | -299.2% | -92.1% | VVOS |
| FY2021 | $30M | $20M | -90.8% | -120.7% | RCEL |
| FY2022 | $30M | $20M | -79.9% | -156.2% | RCEL |
| FY2023 | $50M | $10M | -85.1% | -125.3% | RCEL |
| FY2024 | $60M | $20M | -88.1% | -74.3% | VVOS |
| FY2025 | $70M | $20M | -59.4% | -114.1% | RCEL |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RCEL | VVOS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $506.7M | $1.9M | Larger Scale | RCEL |
| Trailing P/E Ratio Valuation | 10.3x | N/M | Lower Multiple | RCEL |
| Forward P/E Ratio Valuation | 10.3x | N/M | Lower Multiple | RCEL |
| Revenue Growth (YoY) Growth | +53.1% | +34.9% | Higher Growth | RCEL |
| Operating Margin (TTM) Profitability | -33.9% | -107.9% | Higher Margin | RCEL |
| Net Profit Margin Profitability | -42.6% | -121.8% | Higher Margin | RCEL |
| Return on Equity (ROE) Capital Efficiency | -1746.3% | -8585.3% | Higher ROE | RCEL |
| 52-Week Range Position Momentum | 82% ($3โ$18) | 0% ($0โ$3) | Stronger Trend | RCEL |
| Beta / 30D Volatility Risk Regime | 1.54ฮฒ ยท 65% Vol | 1.70ฮฒ ยท 111% Vol | Lower Realized Risk | RCEL |
| Unified Institutional Score Composite Signal | 45.6 / 100 (HOLD) | 36.4 / 100 (SELL) | Higher Composite | RCEL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RCEL vs VVOS Buy Guide
RCEL
CONSOLIDATION
17d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
VVOS
BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RCEL nor VVOS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.